ADVFN US – Market Content Editor
-
Aptevo Shares Drop Despite Encouraging AML Trial Results
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares plunged about 18% on Tuesday even after the company reported promising interim clinical results for its acute myeloid leukemia (AML) treatment candidate, mipletamig. The clinical-stage biotech said mipletamig, when combined with venetoclax and azacitidine, achieved an 86% clinical benefit rate in newly diagnosed AML patients who are elderly or considered…
-
Celularity Strikes Up to $35M Licensing Deal for Biomaterials Portfolio
Celularity Inc. (NASDAQ:CELU) announced it has signed agreements for a strategic commercialization partnership involving its placental-derived biomaterials portfolio, a transaction that could generate up to $35 million through upfront and milestone-based payments. The deal, expected to close by April 15, 2026, grants an exclusive license to Celularity’s commercial-stage biomaterials products along with certain development-stage programs.…
-
Rivian Shares Rise After TD Cowen Upgrade Ahead of R2 Launch
Rivian Automotive (NASDAQ:RIVN) shares gained about 5% Tuesday morning after TD Cowen upgraded the electric vehicle maker to Buy from Hold and set a $20 price target. The stock had closed Monday’s session at $15.87. The upgrade followed a detailed demand assessment of Rivian’s upcoming R2 model conducted by TD Cowen analyst Itay Michaeli. Michaeli…
-
Zoom Expands AI Platform With New Workflow Automation Features
Zoom Communications Inc. (NASDAQ:ZM) announced an expansion of its enterprise artificial intelligence platform, introducing new workflow orchestration capabilities designed to automate tasks across its Workplace, Phone and customer experience products. The new features allow organizations to trigger automated actions and cross-system workflows directly from meetings, calls and customer interactions, integrating collaboration tools with broader enterprise…
-
IBM and Lam Research Team Up to Advance Sub-1nm Chip Technology
IBM (NYSE:IBM) and Lam Research Corp. (NASDAQ:LRCX) have announced a five-year partnership focused on developing next-generation semiconductor processes and materials for logic scaling below the 1-nanometer threshold. The collaboration will concentrate on creating new materials, fabrication techniques and High NA EUV lithography processes aimed at advancing IBM’s long-term logic scaling roadmap. The joint effort will…
-
Citigroup CEO Says Q1 Investment Banking Fees Tracking Mid-Teens Growth
Citigroup Inc. (NYSE:C) Chief Executive Officer Jane Fraser said Tuesday that the bank’s investment banking fees are on track to rise by a mid-teens percentage in the first quarter compared with the same period last year. Speaking at an RBC conference, Fraser added that Citigroup’s markets division is also expected to post growth in the…
-
Vertex Shares Jump After Positive Phase 3 Kidney Drug Results
Vertex Pharmaceuticals (NASDAQ:VRTX) shares climbed about 6% to $488.52 in premarket trading Thursday after the company reported encouraging results from a late-stage clinical trial of its kidney disease treatment povetacicept and said it plans to pursue U.S. regulatory approval. The drug is being developed to treat IgA nephropathy and showed a 52% reduction in proteinuria—a…
-
Hims & Hers Shares Jump on Analyst Upgrades After Novo Nordisk Partnership
Hims & Hers Health (NYSE:HIMS) shares climbed about 10% on Tuesday, extending Monday’s sharp rally of nearly 49% after analysts upgraded the stock following the company’s newly announced partnership with Novo Nordisk (NYSE:NVO). The collaboration, unveiled Monday, enables Hims & Hers to offer commercially available doses of Ozempic and Wegovy—including a newly developed pill formulation—as…
-
Via Transportation Shares Slip After Short Seller Challenges Platform Narrative
Via Transportation (NYSE:VIA) shares dropped about 2% on Tuesday after short seller Bleecker Street Research published a report questioning the company’s positioning as a software platform. In the report, Bleecker Street argued that Via’s operations resemble those of a labor-intensive transit contractor rather than a technology-driven platform business. The firm said its review of more…
-
Ondas Shares Gain After $15.8M Israeli Demining Contract
Ondas Inc. (NASDAQ:ONDS) shares climbed about 4% on Tuesday after the company said its subsidiary, 4M Defense, secured a $15.8 million initial contract under a demining program in Israel. The order represents the first stage of a broader national land-clearing initiative valued at more than $30 million. Additional phases could add another $30 million in…